Search PubMed⌕ Search

PubMed · 8434250

[Current aspects in ergometry].

Abstract

Exercise testing remains an important non-invasive diagnostic test modality in patients with coronary artery disease. In recent years considerable advances have been achieved in the test methodology and in interpretation. The following points are important for the test methodology: (1.) The optimal exercise time is 8-12 minutes. (2.) The stepwise increases in work load should be as small as possible (ideally, according to the ramp protocol). (3.) Whenever possible patients should be tested on a symptom-limited basis. Submaximal ergometry is only indicated in the 2-3 weeks after acute myocardial infarction. (4.) The value of the exercise test depends mainly on the double product achieved (maximal systolic blood pressure x maximal heart rate). The interpretation of the exercise test should consider the clinical and hemodynamic responses and ST-segment changes. ST-segment depressions are the most important diagnostic parameter. The ECG localization (most frequently lateral wall) does not necessarily correspond to the anatomic localization. Exercise capacity and blood pressure response are important prognostic variables.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P Dubach, K Litscher, R Ratti, W H Reinhart. 1993-02-13. [Current aspects in ergometry].. https://pubmed.ncbi.nlm.nih.gov/8434250/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Impact of presentation of research results on likelihood of prescribing medications to patients with left ventricular dysfunction.

This study was conducted to evaluate willingness to prescribe medication based on identical data presented in different outcome terms to health professionals of varied discipline, geographic location, and level of training. Cross-sectional survey using a self-administered questionnaire was performed in 400 health professionals (physicians, pharmacists, physicians-in-training, and pharmacy students) in the United States and Europe. Data reflecting a clinical trial were presented in 6 outcome terms: 3 terms describing identical mortality (relative risk reduction, absolute risk reduction, and number of patients needed to be treated to prevent 1 death); and 3 distractors (increased life expectancy, decreased hospitalization rate, and decreased cost). Willingness to prescribe and rank order of medication preference assuming willingness to prescribe were measured. The results of the study showed that willingness to prescribe and first choice preference were significantly greater when study results were presented as relative risk reduction than when identical mortality data were presented as absolute risk reduction or number of patients needed to be treated to avoid 1 death (p <0.001). Increase in life expectancy was the most influential distractor. In conclusion, this study, performed in the era of "evidence-based medicine," demonstrates that the method of reporting research trial results has significant influence on health professionals' willingness to prescribe. The high numerical value of relative risk reduction and the concrete and tangible quality of increased life expectancy exert greater influence on health professionals than other standard outcome terms.

Cardiovascular Agents↗